NEWS FOR IMMEDIATE RELEASE: 09.01.2020
LAKEWOOD, CO – Mesa Laboratories, Inc. (NASDAQ:MLAB) announced it has entered into a strategic distributor agreement with Tyglar. The two companies intend to collaborate in the market growth and development of critical validation products.
The Tyglar-developed MeCo product line enables validation engineers to achieve consistency and robustness between validation cycles with controlled, reproducible placement of biological indicators and thermocouples together in the most difficult to sterilize locations. Mesa Labs will globally distribute MeCo products in addition to Tyglar’s future developed critical validation accessories.
“The alliance with Tyglar further propels our long-term initiative to deliver innovative validation solutions to the pharmaceutical and biotech industries,” said Peter Jung, Vice President and General Manager of Mesa Labs’ Sterilization Disinfection Control business. “We look forward to introducing Tyglar’s high quality products and see them positively impact the validation market worldwide.”
Tyglar was established when its founders, both experts, one in the pharmaceutical/biotech industry and the other at one of Europe’s product development companies, joined forces to develop innovative, high-tech validation tools for different types of validations. Founder Iwein Denayer’s over 15 years of experience in sterilization-in-process and pharmaceutical validation inspired him to develop tools and accessories to assist engineers to improve validation results along with eliminating repeat validation runs due to a failed process.
About Sterilization Disinfection Control at Mesa Labs’
Mesa Labs’ Sterilization Disinfection Control division provides testing services, along with the manufacture and marketing of biological, chemical and cleaning indicators used to assess the effectiveness of cleaning, disinfecting, and sterilization processes (including steam, gas, hydrogen peroxide, ethylene oxide and radiation processes) in the hospital, dental, medical device, biotechnology and pharmaceutical industries.
Contact Mesa Labs to learn more about MeCo:
+33 (0)4 78 90 56 88
Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements contained herein that are not statements of historical fact may be forward-looking statements, and may also relate to a variety of matters including, without limitation, statements related to the Agreement with Tyglar, Mesa Laboratories’ ability to distribute the products according the Agreement, Mesa Laboratories’ ability to realize the full amount of the revenues and potential under its agreements, and other statements that are not purely statements of historical fact. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Mesa Labs and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Mesa Labs undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. These statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Mesa Labs in general, see the risk disclosures in the Annual Report on Form 10-K of Mesa Labs for the year ended March 31, 2020 and in its subsequent reports on Forms 10-Q and 8-K and other filings made with the U.S. Securities and Exchange Commission. We assume no obligation to update the information in this press release.
TYGLAR Mesa France
Juniorslaan 120 Chassieu, France
B-2811 Leest 2 Rue Auguste Fresnel
Belgium 69680 Chassieu Cedex – France
+32 (0)15 64 45 02 Phone: +33 (0)4 78 90 56 88